What to Expect From Screening For Idiopathic Hypersomnia (IH)
Conquest Research is dedicated to supporting individuals with Idiopathic Hypersomnia by offering access to clinical trials focused on advancing potential treatment options. Participant safety is our top priority, and all volunteers complete a thorough screening process to determine eligibility. This screening process includes:
Idiopathic Hypersomnia (IH) is a chronic sleep disorder characterized by excessive daytime sleepiness despite getting adequate sleep at night. People with IH may struggle to feel alert during the day, experience unrefreshing sleep, and have difficulty waking up. While there is no known cure, treatment options are available to help manage symptoms and improve daily functioning.
Qualifications For An Idiopathic Hypersomnia Clinical Trial:
As a participant in our Idiopathic Hypersomnia (IH) clinical trial, certain eligibility criteria must be met. If you qualify, we invite you to consider participating and helping advance the development of potential new treatments.
You may be eligible to participate if you:
– Are between 18–65 years of age
– Have a diagnosis of Idiopathic Hypersomnia (IH)
Razones para unirse a una Idiopathic Hypersomnia Ensayo clínico
In addition to improving your quality of life and supporting the development of new treatments, participating in an Idiopathic Hypersomnia clinical trial may offer additional benefits for participants.
Frequently Asked Questions About An Idiopathic Hypersomnia (IH) Ensayo clínico

Join an Idiopathic Hypersomnia Clinical Trial Today!
Struggling with excessive daytime sleepiness despite getting enough sleep? Join our Idiopathic Hypersomnia (IH) clinical trial and help advance potential new treatment options. Complete the form today to see if you qualify.



